Egil B. S.
- Country
- Norway
- Department
- Department of Oncology
Research Overview
Data & Insights
Has run more than one trial at 0 of 24 partner sites.
Specializations
Breast Cancer Research
This investigator specializes in studying HER2-positive breast cancer treatments, with particular emphasis on innovative therapeutic approaches for non-metastatic cases.
- HER2-positive breast cancer management
- Neoadjuvant therapy optimization
- Molecular subtype analysis
Key focus includes evaluating treatment responses in molecularly HER2-enriched breast cancer subtypes.
Targeted Therapies
Research interests center on novel targeted therapeutic approaches, particularly exploring the efficacy of trastuzumab deruxtecan in breast cancer treatment.
- Antibody-drug conjugates
- Targeted monotherapy applications
- Treatment response assessment
Special attention is given to evaluating therapeutic outcomes through pathologic complete remission assessment.
Precision Medicine
The investigator focuses on biology-driven treatment selection approaches in breast cancer therapy, emphasizing personalized medicine strategies.
- Molecular profiling applications
- Biomarker-based treatment selection
- Therapeutic response prediction
Research encompasses comparative treatment strategies between standard and novel therapeutic approaches.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.